Next Article in Journal
Quantum Mechanical Calculations of Redox Potentials of the Metal Clusters in Nitrogenase
Next Article in Special Issue
Ugi Four-Component Reactions Using Alternative Reactants
Previous Article in Journal
Supramolecular Crystal Networks Constructed from Cucurbit[8]uril with Two Naphthyl Groups
Previous Article in Special Issue
Catalytic Performance of Immobilized Sulfuric Acid on Silica Gel for N-Formylation of Amines with Triethyl Orthoformate
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 1
10.3390/molecules28010064
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

One-Pot Solvent-Involved Synthesis of 5-O-Substituted 5H-Chromeno[2,3-b]pyridines

by
Yuliya E. Ryzhkova
,
Fedor V. Ryzhkov
,
Michail N. Elinson
*,
Oleg I. Maslov
and
Artem N. Fakhrutdinov
N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, 47 Leninsky Prospekt, 119991 Moscow, Russia
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(1), 64; https://doi.org/10.3390/molecules28010064
Submission received: 28 November 2022 / Revised: 8 December 2022 / Accepted: 17 December 2022 / Published: 21 December 2022
(This article belongs to the Special Issue Green and Highly Efficient One-Pot Synthesis and Catalysis)
Browse Figures
Versions Notes

Abstract

:
Chromeno[2,3-b]pyridines are substances demanded in medicinal and material chemistry. PASE (pot, atom, and step economy) and in particular one-pot approaches are key green chemistry techniques that are applied for the synthesis of heterocyclic compounds. In this case, the PASE approach was extended with ‘component economy’, as solvent was used also as reactant (solvent-involved reaction). This approach was adopted for the one-pot synthesis of previously unknown O-substituted 5-alkoxy-5H-chromeno[2,3-b]pyridines via two-step transformation, namely the reaction of salicylaldehydes and malononitrile dimer, with the subsequent addition of alcohol. The mechanistic studies revealed the possibility of concurrent reaction. The studies aided in optimizing the reaction conditions for the best yields (77–93%). Thus, the one-pot reaction proceeds efficient and quickly, and the work-up procedure (only simple filtering) is very convenient. The structure of synthesized chromeno[2,3-b]pyridines was confirmed by 2D NMR spectroscopy.

Graphical Abstract

1. Introduction

Global ecological awareness has made green chemistry a broad, beneficial and promising area of organic chemistry [1,2]. Green chemistry is based on 12 principles [1] that lead to the development of the simplest synthetic approach with the utilization of the least number of components (the less toxic, the better); the result should carry the least number of by-products and environmental threats.
The current level of chemistry does not allow all 12 principles to be applied to resolve all drawbacks and limitations (for example, avoiding solvents or special precursors) in the development of every new process. Thereby, in synthetic chemistry, the PASE approach has become widespread [3,4,5,6,7] and it is currently a key green technique [4]. This approach is focused on the economy (E) of pot (P), atom (A) and steps (S). Atomic economy states that the majority of atoms in a reaction become a component of the final product. This concept prevents waste; however, if the waste is inevitable, according to green chemistry, water is the best by-product. Step economy is linked to the energy efficiency principle; it is preferable to have the fewest stages (separate transformations, work-ups) [8] and to have all transformations in one pot [8,9].
Another green principle is to utilize a less toxic solvent or completely reduce it [10]. Solvent-free reactions [11,12], solid-state reactions [13,14,15]—in case of solid aldehydes, on-water (water-assisted), and reactions in emulsions [12,16,17,18] are examples of green methods with varying solvent roles that were developed with that principle. These approaches greatly reduce the amount of solvent, increase the reaction rate [19,20] and produce excellent yields [15,16,20].
Among the approaches mentioned above, reactions in which solvents are involved in the transformations [21] have never received special attention. However, it would be a consistent extension of such approaches. More than that, the utilization of solvent as a reactant is applied in polymer [22] and organic syntheses (Friedel–Crafts acylation) as they possess several advantages: they are simple, reduce waste, and are easy to work up.
Chromenopyridine derivatives have a wide spectrum of properties that are useful for medicinal chemistry. Among them, glucocorticoid receptor activity [23], antiproliferative [24], anti-tumor [25] anti-rheumatic [26], anti-histaminic [26] and anti-asthmatic [27] properties are shown. Pranoprofen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic actions [28].
Chromenopyridine derivatives with an additional atom of oxygen at the 5-position are a more specific class of compounds. Amlexanox (Figure 1) is an anti-allergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis [29]. Another practically useful compound of this class is 5-phenoxy-5H-chromeno[2,3-b]pyridine (Figure 1) [30], which, when placed on the surface of low-carbon steel, prevents its corrosion, even in a 15% hydrochloric acid solution [30]. There are some other derivatives with similar properties [31,32].
Among these compounds, the structure of 5-phenoxy-5H-chromeno[2,3-b]pyridine (Figure 1) provides the best potential for modification of the O-substitution. Furthermore, 5-phenoxy-5H-chromeno[2,3-b]pyridine is the only structure known to have an additional oxygen substitution [30]. At the same time, phenol, which is used for the synthesis, is quite a toxic component. It would be better to replace phenol fragments with less toxic and more cheap alcohols. However, the synthesis of 5-phenoxy-5H-chromeno[2,3-b]pyridine is carried out in ethanol [30], and no 5-ethoxy-5H-chromeno[2,3-b]pyridine products were obtained in this procedure.
We have accomplished several syntheses of chromeno[2,3-b]pyridines [5,33] and some green transformations with different roles of solvent, among them [12] on-solvent [12], on-water [18], and solid-state ([15] procedures. In addition to these green methods, we would like to present the first synthesis of O-substituted 5-alkoxy-5H-chromeno[2,3-b]pyridines, in which solvent is used as a reactant (solvent-involved—[21]) and plays a role in the final nucleophilic addition, becoming a fragment of the final structure. It delivers atom economy, reduces the number of used components, and thereby makes the whole process greener.

2. Results and Discussion

2.1. Formation of 5-Alkoxy-5H-Chromeno[2,3-b]pyridine 4

Previously we synthesized various types of 5-C- and 5-P-chromeno[2,3-b]pyridines [5,33,34,35,36,37,38]. In general, the interaction of a carbonyl group with a CH acid and the subsequent addition of another CH acid are easily feasible. Modifying CH acid to another nucleophilic agent, on the other hand, is a more difficult task. We discovered this for the first time in the synthesis of 5-P-chromeno[2,3-b]pyridines [5]. To complete the synthesis, we had to use an aprotic solvent (CH3CN), which enhances the nucleophilic properties of reactants.
After C- and P-substituted products were synthesized, we concentrated on 5-O-substituted chromeno[2,3-b]pyridines. It turns out that only a few examples are known, and only a few of them have been synthesized with one-pot or multicomponent methods [39,40,41].
One such example is the multicomponent synthesis of 2,4-diamino-5-phenoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile (Scheme 1) [30]. Among other things, it is difficult to assess the generality of the reaction, since the authors presented only one such compound. The mechanism of the reaction was also not described thoroughly.
We were encouraged to deeply investigate such processes in case of malononitrile dimer. First of all, we synthesized chromene 5a for the mechanism investigation. However, during the recrystallization of chromene 5a after the reaction (Scheme 2), some byproducts were found.
NMR analysis (see Section 2.4 for more detailed analysis) revealed that harsh recrystallization results in the formation of 5-alkoxy-5H-chromeno[2,3-b]pyridine (Figure 2, Scheme 3 in Section 2.2).
Thus, in this article, we present a mechanistic investigation of the formation of 5-alkoxy-5H-chromeno[2,3-b]pyridine with proven structure (2D NMR) as well as a convenient approach to the new substituted 5-O-chromeno[2,3-b]pyridines.

2.2. Mechanism of Formation of 5-Methoxy-5H-Chromeno[2,3-b]pyridine 4a

In this case, the addition of MeOH to chromene 5a appears to allow the formation of 5-O-chromeno[2,3-b]pyridine. We have carried out several one-pot transformations to prove this (Scheme 3).
A two-step transformation results in 5-O-chromeno[2,3-b]pyridine 4a after the complete formation of intermediate 5a (it precipitates, then redissolves) (Scheme 3). The intermediate 5a was detected in the reaction mixture (NMR). The steps of the two-step transformation were controlled by temperature. The final cyclization to 4a (step II, Scheme 3) demands heating at reflux.
If the heating is provided immediately without complete formation (precipitation) of intermediate 5a, the process affords a mixture of compounds 8 and 4a. Thus, in this case 5-O-chromeno[2,3-b]pyridine 4a is formed in a multicomponent reaction, but concurrent cascade formation of chromeno[2,3-b]pyridine derivative 8 [42] also occurs (Scheme 3).
Molecules 28 00064 sch003 550
Scheme 3. Two-step one-pot (or multicomponent) formation of 5-O-chromeno[2,3-b]pyridine 4a and cascade formation of chromeno[2,3-b]pyridine derivative 8. For the conditions see Table 1 in Section 2.3, Entry 1.
Scheme 3. Two-step one-pot (or multicomponent) formation of 5-O-chromeno[2,3-b]pyridine 4a and cascade formation of chromeno[2,3-b]pyridine derivative 8. For the conditions see Table 1 in Section 2.3, Entry 1.
Molecules 28 00064 sch003
Based on these results, we decided to accomplish the process in the one-pot two-step format (Scheme 3). In this case, stage I was completed in one hour without heating to avoid the formation of unsubstituted chromeno[2,3-b]pyridine derivative 8 [42]. Stage II also took half an hour, but with heating at reflux. At the end of the two-step transformation, only 5-O-chromeno[2,3-b]pyridine 4a was detected.
Based on our earlier results [5,33,38] and data from the literature [43], we propose the following one-pot two-step cascade transformation mechanism (Scheme 4). The first stage of the one-pot process was a Knoevenagel condensation with the formation of intermediate 6 and the expulsion of a hydroxide anion [44]. This hydroxide anion catalyzed Pinner cyclization of the adduct 6 into the unsaturated intermediate 5. At the second stage of the one-pot process, the addition of alcohol to the double bond of the intermediate compound 5 according to Markovnikov’s rule took place. The resulting intermediate 7 underwent deprotonation, tautomerization, and Pinner-type cyclization. After that, another tautomerization and protonation occurred to yield 5-O-chromeno[2,3-b]pyridine 4.
It should be noted that obtained 5-O-chromeno[2,3-b]pyridines 4 are unstable in DMSO solution. In publication [45], the authors claimed to have synthesized 2,4-diamino-5-ethoxy-9-methoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile. Those data, however, are not available, neither in the text of the article nor in the Supplementary Materials [45]. The authors claim that this is due to the fact that the compound 4a is unstable in DMSO-d6 and in solid form. Indeed, we observed the decomposition of 5-O-substituted chromeno[2,3-b]pyridines 4 upon standing in DMSO-d6 in a NMR tube at room temperature, while recording NMR spectra. We solved this problem by preparing a fresh solution. In solid form, these compounds 4 turned out to be stable.
In the case of 5-P and 5-C-substituted chromeno[2,3-b]pyridines, corresponding CH acid or trialkyl phosphites acted similarly to alcohol, as described in our research (Scheme 3). It should be noted that 5-P- and 5-C-chromeno[2,3-b]pyridines were synthesized under the same conditions (in ethanol) without any quantity of 5-alkoxy-5H- chromeno[2,3-b]pyridine formation. Moreover, 5-P and 5-C-substituted chromeno[2,3-b]pyridines [5,33,34,35,36,37,38] were stable in DMSO. This affirms that 5-P- and 5-C-products are thermodynamically more stable, and that 5-alkoxy derivatives are kinetic products.

2.3. One-Pot Synthesis of 5-Alkoxy-5H-Chromeno[2,3-b]pyridines 4a–i

As the mechanism of the reaction had been established, we were interested in optimizing the reaction conditions. Further, transformations of salicylaldehyde 1a, malononitrile dimer 2 and alcohol 3a were done in the one-pot, two-step format (Scheme 3, Path A, two-step, one-pot) to avoid the concurrent formation of byproduct 8 (Scheme 3, Path B). Namely, salicylaldehyde 1a and malononitrile dimer 2 in alcohol were stirred until the intermediate 5 was precipitated (Stage I), and the reaction mixture was heated at reflux to produce 5-O-chromeno[2,3-b]pyridines 4 (Stage II). The list of conditions is presented in Table 1.
Table
Table 1. Optimization of reaction conditions on the synthesis of 4a 1.
Table 1. Optimization of reaction conditions on the synthesis of 4a 1.
EntryCatalystCat. Amount (mol%)Solvent Amount st. II (mL)Time st. II (h)Temp. (°C)Yield (%) 2
1Morpholine102016580
2Piperidine102016582
3Pyridine102016571
4Et3N102016594
5AcONa102016548 3
6NaOH102016552 3
7KF102016529 3
8Et3N202016595
9Et3N101516590
10Et3N102516582
11Et3N10200.56593
12Et3N102026594
13Et3N10200.523 (rt)10 3
1 Reaction conditions: salicylaldehyde 1a (1 mmol), malononitrile dimer 2 (1 mmol), methanol 3a (1 mmol) were stirred in 10 mL of corresponding alcohol at room temperature for 1 h, then another portion of alcohol was added, and reaction mixture was heated at reflux for time indicated in Table 1. 2 Isolated yields. 3 NMR data.
The data from Table 1 indicate that amines (Entries 1–4, 8–13) tend to produce higher yields of 4a than inorganic catalysts. Stage I can be accomplished with any type of catalyst in high yields. It is possible that amines form a transitional intermediate that increases the rate of the nucleophilic addition in Stage II.
The reaction in Stage I is easily catalyzed, and the product precipitates in one hour process without heating. In Stage II, there should be a balance between reagent and product solubility, and the amount of alcohol is important (Entries 8–10). Thus, 10 mL of methanol were used in Stage I, and another 20 mL of methanol were used in Stage II to achieve the best results. According to Entries 8, 11, 12, Stage II finishes in a half hour.
Among the amines used (Entries 1–4), triethylamine (Entry 4) is the best catalyst. This is probably due to its strong basicity. 10% of catalyst is enough for the reaction (Entries 4, 8).
To sum up, Entry 11 is the most optimal condition for this new transformation. To isolate the synthesized compound, when the reaction was finished, the reaction mixture was left at room temperature for 3 h to crystallize the final compound 4 in pure form.
Under the optimal conditions, multicomponent reactions of salicylaldehydes 1a–c, malononitrile dimer 2 and alcohols 3a–c were carried out. 5-Alkoxy-5H-chromeno[2,3-b]pyridines 4a–i were obtained in 77–93% yields (Table 2).
It should be noted that regardless of the type of alcohol, the highest yields of chromeno[2,3-b]pyridine 4a–c were obtained in the reaction with salicylaldehyde 1a (Table 2). When electron-donor or halogen substituted salicylaldehyde 1 is used, the yields decrease slightly but remain comparable. This is preusmably due to the greater solubility of the intermediate 5 in alcohols in these cases. When alcohol was changed, the highest yields of chromeno[2,3-b]pyridines 4 were obtained with methanol 3a (Table 2). Most likely, this can be explained by steric factors.

2.4. 2D-NMR Study of the Structure of Compound 4d

The structure of the obtained compounds 4a–i was confirmed by 1H and 13C NMR data, IR spectroscopy, and mass spectrometry. The structure of the compound 4d was confirmed by various NMR correlation spectroscopy techniques (Figure 3 and Figure 4).
The assignment of one-dimensional (1D) 1H and 13C-NMR spectra signals was performed using two-dimensional (2D) NMR experiments such as 1H-13C HSQC and 1H-13C HMBC (Figure 4). 1H-13C HSQC showed two NH2-groups which had no cross-peaks in the spectrum. In the HMBC spectrum, the coupling between amino-protons and C3 was found (Figure 3 and Figure 4). Additionally, 5-OMe gave the only correlation with C5 through three chemical bonds. This is confirmed by the spin interaction from the HMBC spectrum of H5 with the carbons of the benzene and pyridine rings (Figure 3 and Figure 4).
The full correlation of signals from one-dimensional 1H and 13C-NMR spectra with the corresponding atoms of compound 4d is as follows:
1H-NMR (500 MHz, DMSO-d6) δ: 2.77 (s, 3H, 5-OCH3), 3.79 (s, 3H, 8-OCH3), 5.77 (s, 1H, C(H5)), 6.62 (s, 2H, 2-NH2), 6.67 (s, 2H, 4-NH2), 6.73 (d, 4J = 2.5 Hz, 1H, C(H9) Ar), 6.81 (dd, 3J = 8.5 Hz, 4J = 2.5 Hz, 1H, C(H7) Ar), 7.32 (d, 3J = 8.5 Hz, 1H, C(H6) Ar) ppm.
13C-NMR (126 MHz, DMSO-d6) δ: 49.7 (5-OCH3), 55.4 (8-OCH3), 65.9 (C5), 70.3 (C3), 86.5 (C4a), 100.7 (C9), 110.9 (C7), 111.2 (C5a), 116.3 (CN), 130.4 (C6), 152.3 (C9a), 158.4, 160.0 (C4, C1a), 160.23, 160.24 (C2, C8) ppm.
Detailed 1D 1H and 13C-NMR spectra and 2D NMR spectra of the compound 4d are presented in the Supplementary Materials (Figures S19–S22).

3. Materials and Methods

3.1. General Information

The solvents and reagents were purchased from commercial sources and used as received. 2-Aminoprop-1-ene-1,1,3-tricarbonitrile (malononitrile dimer) 2 was synthesized from malononitrile according to the literature [46].
All melting points were measured with a Gallenkamp melting-point apparatus (Gallenkamp & Co., Ltd., London, UK) and were uncorrected. 1H and 13C-NMR spectra were recorded in DMSO-d6 with Bruker AM300 and Bruker AV500 spectrometers (Bruker Corporation, Billerica, MA, USA) at ambient temperature. Chemical shift values are relative to Me4Si. Some 1H-NMR spectra have underestimated NH2 signals integrals. These protons were exchanged with D2O (it is present as an impurity in DMSO-d6). Two-dimensional (2D) NMR spectra were registered with a Bruker AV400 spectrometer (Bruker Corporation, Billerica, MA, USA) at ambient temperature. The IR spectrum was recorded with a Bruker ALPHA-T FT-IR spectrometer (Bruker Corporation, Billerica, MA, USA) in a KBr pellet. MS spectra (EI = 70 eV) were obtained directly with a Kratos MS-30 spectrometer (Kratos Analytical Ltd., Manchester, UK). High-resolution mass spectra (HRMS) were measured on a Bruker micrOTOF II (Bruker Corporation, Billerica, MA, USA) instrument using electrospray ionization (ESI).

3.2. One-Pot Synthesis of 5-Alkoxy-5H-Chromeno[2,3-b]pyridines 4a–i

Salicylaldehyde 1a–c (1 mmol) and malononitrile dimer 2 (1 mmol, 132 mg) were stirred in alcohol 3a–c (10 mL) for 1 h at room temperature. The formation of a thick yellowish precipitate was observed. Another portion of alcohol 3a–c (20 mL) was added to the precipitate with stirring, and the reaction mixture was refluxed for an additional 30 min. After the reaction was completed, the flask was left at room temperature for 3 h. The solid was filtered, washed with well-chilled ethanol/water mixture (1:1, 2 × 2 mL), and dried to isolate pure 5-alkoxy-5H-chromeno[2,3-b]pyridine 4a–i.
2,4-Diamino-5-methoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4a, (white powder, 250 mg, 93%), mp. 297–298 °C (decomp.) (from MeOH), FTIR (KBr), cm−1: 3458, 3345, 3228, 2203, 1624, 1600, 1564, 1408, 1217, 1049. 1H-NMR (300 MHz, DMSO-d6) δ 2.82 (s, 3H, OCH3), 5.85 (s, 1H, CH), 6.64 (s, 2H, NH2), 6.72 (s, 2H, NH2), 7.15–7.29 (m, 2H, 2 CH Ar), 7.38–7.50 (m, 2H, 2 CH Ar) ppm. 13C-NMR (126 MHz, DMSO-d6) δ 48.7, 66.2, 70.4, 88.5, 115.8, 116.6, 122.1, 124.7, 128.9 (2C), 151.3, 156.7, 159.2, 159.8 ppm. MS (EI, 70 eV) m/z (%): 268 [M]+ (5), 237 (100), 209 (3), 171 (21), 145 (3), 118 (6), 92 (3), 66 (21), 63 (6), 29 (16). HRMS-ESI: m/z [M + H]+, calcd for C14H13N4O2 269.1039, found 269.1043.
2,4-Diamino-5-ethoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4b, (white powder, 246 mg, 87%), mp. 294–295 °C (decomp.) (from EtOH), FTIR (KBr), cm−1: 3461, 3367, 3226, 2205, 1625, 1601, 1564, 1407, 1216, 1057. 1H-NMR (300 MHz, DMSO-d6) δ 0.93 (t, 3J = 7.0 Hz, 3H, CH3), 2.96–3.13 (m, 2H, OCH2), 5.83 (s, 1H, CH), 6.60 (s, 2H, NH2), 6.69 (s, 2H, NH2), 7.12–7.27 (m, 2H, 2 CH Ar), 7.35–7.51 (m, 2H, 2 CH Ar) ppm. 13C-NMR (126 MHz, DMSO-d6) δ 15.3, 58.2, 65.6, 70.4, 87.1, 116.3, 119.9, 123.8, 128.8, 129.5, 129.7, 151.1, 158.4, 159.9, 160.3 ppm. MS (EI, 70 eV) m/z (%): 282 [M]+ (3), 237 (100), 209 (2), 180 (1), 171 (13), 145 (2), 118 (3), 77 (4), 66 (13), 29 (34). HRMS-ESI: m/z [M + H]+, calcd for C15H15N4O2 283.1195, found 283.1200.
2,4-Diamino-5-propoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4c, (white powder, 264 mg, 89%), mp. 293–294 °C (decomp.) (from n-PrOH), FTIR (KBr), cm−1: 3464, 3357, 3235, 2198, 1627, 1602, 1564, 1408, 1220, 1069. 1H-NMR (300 MHz, DMSO-d6) δ 0.73 (t, 3J = 7.4 Hz, 3H, CH3), 1.42–1.25 (m, 2H, CH2), 2.84–3.02 (m, 2H, OCH2), 5.89 (s, 1H, CH), 6.62 (s, 2H, NH2), 6.69 (s, 2H, NH2), 7.13–7.28 (m, 2H, 2 CH Ar), 7.37–7.51 (m, 2H, 2 CH Ar) ppm. 13C-NMR (75 MHz, DMSO-d6) δ 10.6, 22.6, 64.1, 65.6, 70.3, 86.9, 116.2, 119.7, 123.8, 128.8, 129.5, 129.7, 151.1, 158.4, 159.8, 160.3 ppm. MS (EI, 70 eV) m/z (%): 296 [M]+ (3), 253 (2), 237 (100), 209 (2), 171 (14), 145 (2), 118 (3), 77 (2), 66 (9), 29 (16). HRMS-ESI: m/z [M + H]+, calcd for C16H17N4O2 297.1346, found 297.1352.
2,4-Diamino-5,8-dimethoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4d, (yellowish powder, 239 mg, 80%), mp. 282–283 °C (decomp.) (from MeOH), FTIR (KBr), cm−1: 3464, 3354, 3234, 2197, 1629, 1600, 1559, 1403, 1173, 1048. 1H-NMR (300 MHz, DMSO-d6) δ 2.79 (s, 3H, OCH3), 3.81 (s, 3H, CH3O-Ar), 5.79 (s, 1H, CH), 6.62 (s, 2H, NH2), 6.67 (s, 2H, NH2), 6.75 (s, 1H, 1 CH Ar), 6.83 (d, 3J = 8.3 Hz, 1H, 1 CH Ar), 7.34 (d, 3J = 8.3 Hz, 1H, 1 CH Ar) ppm. 13C-NMR (75 MHz, DMSO-d6) δ 49.6, 55.4, 65.9, 70.4, 86.5, 100.7, 110.9, 111.2, 116.2, 130.4, 152.3, 158.4, 160.0, 160.2 (2C) ppm. MS (EI, 70 eV) m/z (%): 298 [M]+ (2), 267 (100), 224 (19), 195 (4), 170 (2), 133 (4), 114 (1), 77 (2), 66 (5), 15 (23). HRMS-ESI: m/z [M + H]+, calcd for C15H15N4O3 299.1144, found 299.1148.
2,4-Diamino-5-ethoxy-8-methoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4e, (yellowish powder, 244 mg, 78%,), mp. 280–281 °C (decomp.) (from EtOH), FTIR (KBr), cm−1: 3472, 3309, 3201, 2200, 1629, 1600, 1566, 1407, 1205, 1050. 1H-NMR (300 MHz, DMSO-d6) δ 0.95 (t, 3J = 6.9 Hz, 3H, CH3), 3.02 (q, 3J = 6.9 Hz, 2H, OCH2), 3.81 (s, 3H, CH3O-Ar), 5.79 (s, 1H, CH), 6.60 (s, 2H, NH2), 6.66 (s, 2H, NH2), 6.74 (d, 4J = 2.1 Hz, 1H, 1 CH Ar), 6.82 (dd, 3J = 8.5 Hz, 4J = 2.1 Hz, 1H, 1 CH Ar), 7.35 (d, 3J = 8.5 Hz, 1H, 1 CH Ar) ppm. 13C-NMR (75 MHz, DMSO-d6) δ 15.3, 55.4, 57.7, 65.3, 70.4, 87.2, 100.8, 110.8, 112.0, 116.3, 130.3, 152.0, 152.1, 158.3, 159.6, 160.2 ppm. MS (EI, 70 eV) m/z (%): 312 [M]+ (2), 267 (100), 224 (26), 195 (4), 170 (2), 141 (2), 133 (7), 77 (3), 66 (8), 29 (47). HRMS-ESI: m/z [M + H]+, calcd for C16H17N4O3 313.1301, found 313.1307.
2,4-Diamino-8-methoxy-5-propoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4f, (yellowish powder, 258 mg, 79%), mp. 284–285 °C (decomp.) (from n-PrOH), FTIR (KBr), cm−1: 3465, 3358, 3237, 2198, 1628, 1601, 1563, 1408, 1175, 1071. 1H-NMR (300 MHz, DMSO-d6) δ 0.73 (t, 3J = 7.4 Hz, 3H, CH3), 1.25–1.41 (m, 2H, CH2), 2.80–2.96 (m, 2H, OCH2), 3.81 (s, 3H, CH3O-Ar), 5.83 (s, 1H, CH), 6.61 (s, 2H, NH2), 6.65 (s, 2H, NH2), 6.73 (d, 4J = 2.1 Hz, 1H, 1 CH Ar), 6.82 (dd, 3J = 8.5 Hz, 4J = 2.1 Hz, 1H, 1 CH Ar), 7.35 (d, 3J = 8.5 Hz, 1H, 1 CH Ar) ppm. 13C-NMR (75 MHz, DMSO-d6) δ 10.6, 22.6, 55.4, 62.4, 65.3, 70.4, 100.7, 110.9, 111.8, 115.7, 116.3, 130.3, 152.1, 157.0, 157.6, 159.6, 160.2 ppm. MS (EI, 70 eV) m/z (%): 326 [M]+ (1), 267 (100), 252 (6), 224 (12), 195 (2), 170 (1), 134 (3), 104 (1), 66 (1), 31 (3). HRMS-ESI: m/z [M + H]+, calcd for C17H19N4O3 327.1457, found 327.1461.
2,4-Diamino-7-chloro-5-methoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4g, (white powder, 257 mg, 85%), mp. 306–307 °C (decomp.) (from MeOH), FTIR (KBr), cm−1: 3460, 3352, 3229, 2201, 1625, 1598, 1561, 1423, 1222, 1051. 1H-NMR (300 MHz, DMSO-d6) δ 2.80 (s, 3H, OCH3), 5.81 (s, 1H, CH), 6.66 (s, 2H, NH2 exch. with D2O), 6.72 (s, 2H, NH2 exch. with D2O), 7.23 (d, 3J = 8.6 Hz, 1H, 1 CH Ar), 7.40–7.50 (m, 2H, 2 CH Ar) ppm. 13C-NMR (75 MHz, DMSO-d6) δ 50.2, 66.0, 70.4, 85.7, 116.2, 118.5, 121.1, 127.5, 128.9, 129.9, 150.2, 158.4, 159.8, 160.4 ppm. MS (EI, 70 eV) m/z (%): 304 [M]+ (37Cl, 1), 302 [M]+ (35Cl, 4), 273 (37Cl, 32), 271 (35Cl, 100), 236 (3), 207 (37Cl, 4), 205 (35Cl, 12), 179 (2), 136 (5), 114 (3), 75 (4), 66 (23), 29 (17). HRMS-ESI: m/z [M + H]+, calcd for C14H12ClN4O2 305.0619 (37Cl), 303.0649 (35Cl), found 305.0622 (37Cl), 303.0653 (35Cl).
2,4-Diamino-7-chloro-5-ethoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4h, (yellowish powder, 244 mg, 77%), mp. 303–304 °C (decomp.) (from EtOH), FTIR (KBr), cm−1: 3467, 3360, 3223, 2197, 1621, 1589, 1562, 1399, 1220, 1051. 1H-NMR (300 MHz, DMSO-d6) δ 0.94 (t, 3J = 6.9 Hz, 3H, CH3), 2.95–3.12 (m, 2H, OCH2), 5.81 (s, 1H, CH), 6.65 (s, 2H, NH2 exch. with D2O), 6.71 (s, 2H, NH2 exch. with D2O), 7.22 (d, 3J = 9.0 Hz, 1H, 1 CH Ar), 7.41–7.51 (m, 2H, 2 CH Ar) ppm. 13C-NMR (75 MHz, DMSO-d6) δ 15.3, 58.4, 65.5, 70.5, 86.5, 116.2, 118.5, 121.8, 127.5, 128.7, 129.7, 150.0, 158.4, 159.7, 160.3 ppm. MS (EI, 70 eV) m/z (%): 318 [M]+ (37Cl, 1), 316 [M]+ (35Cl, 3), 273 (37Cl, 33), 271 (35Cl, 100), 236 (3), 207 (37Cl, 3), 205 (35Cl, 9), 179 (1), 152 (1), 136 (2), 77 (1), 66 (7), 29 (16). HRMS-ESI: m/z [M + H]+, calcd for C15H14ClN4O2 319.0771 (37Cl), 317.0800 (35Cl), found 319.0773 (37Cl), 317.0802 (35Cl).
2,4-Diamino-7-chloro-5-propoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4i, (yellowish powder, 265 mg, 80%), mp. 304–305 °C (decomp.) (from n-PrOH), IR spectrum (ν, cm−1): 3470, 3361, 3227, 2198, 1621, 1598, 1562, 1399, 1222, 1068. 1H-NMR (300 MHz, DMSO-d6) δ 0.71 (t, 3J = 7.4 Hz, 3H, CH3), 1.25–1.40 (m, 2H, CH2), 2.81–2.98 (m, 2H, OCH2), 5.85 (s, 1H, CH), 6.65 (s, 2H, NH2 exch. with D2O), 6.70 (s, 2H, NH2 exch. with D2O), 7.21 (d, 3J = 8.5 Hz, 1H, 1 CH Ar), 7.42–7.48 (m, 2H, 2 CH Ar) ppm. 13C-NMR (75 MHz, DMSO-d6) δ 10.6, 22.6, 64.3, 65.5, 70.4, 86.3, 116.2, 118.5, 121.7, 127.5, 128.8, 129.8, 150.0, 158.4, 159.6, 160.3 ppm. MS (EI, 70 eV) m/z (%): 332 [M]+ (37Cl, 1), 330 [M]+ (35Cl, 3), 273 (37Cl, 33), 271 (35Cl, 100), 243 (1), 207 (37Cl, 4), 205 (35Cl, 11), 152 (2), 136 (5), 92 (1), 66 (14), 41 (11), 29 (33). HRMS-ESI: m/z [M + H]+, calcd for C16H16ClN4O2 333.0932 (37Cl), 331.0962 (35Cl), found 333.0935 (37Cl), 331.0964 (35Cl).

4. Conclusions

To conclude, the synthesis of 5-O-substituted 5H-chromeno[2,3-b]pyridines differs from that of 5-P- and 5-C-substituted derivatives. The nucleophile, which is supposed to interact with the intermediate, determines the final structure.
In this case, the solvent (alcohol) acted as a nucleophile; it interacted with the intermediate formed from salicylaldehyde and malononitrile dimer to form 5-O-substituted 5H-chromeno[2,3-b]pyridines. This two-step, one-pot transformation extends the PASE approach with ‘component economy’ as alcohol is used both as a solvent and a reactant (solvent-involved reaction).
The mechanistic studies revealed the possibility of concurrent processes. These processes tend to form more thermodynamically stable products. Alcohol, as a weak nucleophile, forms the kinetic product, which is unstable in solution.
The mechanistic studies aided in optimizing reaction conditions. Thus, the one-pot, two-step transformation of salicylaldehydes, malononitrile dimer and alcohol proceeds efficiently and quickly with the formation of 5-O-substituted 5H-chromeno[2,3-b]pyridines in high yields of 77–93%. It is easy to isolate the final compounds directly from the reaction mixture.
2D NMR spectroscopy confirmed the proposed structure of synthesized 5H-chromeno[2,3-b]pyridines.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28010064/s1, Figures S1–S18: 1H and 13C Spectra of synthesized compounds 4a–i, Figures S19 and S20: Detailed 1D-NMR Spectra of 4d, Figures S21 and S22: 2D-NMR Spectra of 4d.

Author Contributions

Conceptualization, Y.E.R. and M.N.E.; methodology, Y.E.R. and M.N.E.; validation, F.V.R. and M.N.E.; investigation, Y.E.R. and O.I.M.; resources, M.N.E.; data curation, Y.E.R. and F.V.R.; writing—original draft preparation, Y.E.R. and F.V.R.; writing—review and editing, M.N.E.; supervision, M.N.E.; NMR research, A.N.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article or Supplementary Material.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds 4a–i are available from the authors.

References

  1. Anastas, P.T.; Warner, J.C. Green Chemistry: Theory and Practice; Oxford University Press: New York, NY, USA, 1998; p. 30. ISBN 9780198506980. [Google Scholar]
  2. Anastas, P.; Eghbali, N. Green Chemistry: Principles and Practice. Chem. Soc. Rev. 2010, 39, 301–312. [Google Scholar] [CrossRef] [PubMed]
  3. Muthengi, A.; Zhang, X.; Dhawan, G.; Zhang, W.; Corsinia, F.; Zhang, W. Sequential (3 + 2) cycloaddition and (5 + n) annulation for modular synthesis of dihydrobenzoxazines, tetrahydrobenzoxazepines and tetrahydrobenzoxazocines. Green Chem. 2018, 20, 3134–3139. [Google Scholar] [CrossRef]
  4. Zhang, W.; Yi, W.B. Introduction to PASE Synthesis. In Pot, Atom, and Step Economy (PASE) Synthesis; Springer Briefs in Molecular Science; Springer International Publishing: Cham, Switzerland, 2019; pp. 1–4. [Google Scholar] [CrossRef]
  5. Elinson, M.N.; Vereshchagin, A.N.; Anisina, Y.E.; Fakhrutdinov, A.N.; Goloveshkin, A.S.; Egorov, M.P. Pot-, Atom- and Step-Economic (PASE) Multicomponent approach to the 5-(Dialkylphosphonate)-Substituted 2,4-Diamino-5H-chromeno[2,3-b]pyridine scaffold. Eur. J. Org. Chem. 2019, 2019, 4171–4178. [Google Scholar] [CrossRef]
  6. Moseev, T.D.; Varaksin, M.V.; Gorlov, D.A.; Nikiforov, E.A.; Kopchuk, D.S.; Starnovskaya, E.S.; Khasanov, A.F.; Zyryanov, G.V.; Charushin, V.N.; Chupakhin, O.N. Direct CH/CLi coupling of 1,2,4-triazines with C6F5Li followed by aza-Diels-Alder reaction as a pot, atom, and step economy (PASE) approach towards novel fluorinated 2,2′-bipyridine fluorophores. J. Fluor. Chem. 2019, 224, 89–99. [Google Scholar] [CrossRef]
  7. Romanov, A.R.; Rulev, A.Y.; Ushakov, I.A.; Muzalevskiy, V.M.; Nenajdenko, V.G. One-Pot, Atom and Step Economy (PASE) Assembly of Trifluoromethylated Pyrimidines from CF3-Ynones. Eur. J. Org. Chem. 2017, 2017, 4121–4129. [Google Scholar] [CrossRef]
  8. Zhang, W.; Yi, W.B. Pot, Atom, and Step Economy (PASE) Synthesis; Springer Briefs in Molecular Science; Springer International Publishing: Cham, Switzerland, 2019; ISBN 9783030225964. [Google Scholar] [CrossRef]
  9. Clarke, P.A.; Santos, S.; Martin, W.H.C. Combining pot, atom and step economy (PASE) in organic synthesis. Synthesis of tetrahydropyran-4-ones. Green Chem. 2007, 9, 438–440. [Google Scholar] [CrossRef] [Green Version]
  10. Tanaka, K.; Toda, F. Solvent-Free Organic Synthesis. Chem. Rev. 2000, 100, 1025–1074. [Google Scholar] [CrossRef] [PubMed]
  11. Singh, M.S.; Chowdhury, S. Recent developments in solvent-free multicomponent reactions: A perfect synergy for eco-compatible organic synthesis. RSC Adv. 2012, 2, 4547–4592. [Google Scholar] [CrossRef]
  12. Elinson, M.N.; Vereshchagin, A.N.; Ryzhkov, F.V.; Anisina, Y.E. ’Solvent-free’ and ’on-solvent’ multicomponent reaction of isatins, malononitrile, and bicyclic CH-acids: Fast and efficient way to medicinal privileged spirooxindole scaffold. Arkivoc 2018, 4, 276–285. [Google Scholar] [CrossRef] [Green Version]
  13. Banfi, L.; Guanti, G.; Riva, R.; Basso, A. Multicomponent reactions in solid-phase synthesis. Curr. Opin. Drug Discov. Devel. 2007, 10, 704–714. Available online: https://pubmed.ncbi.nlm.nih.gov/17987522/ (accessed on 20 November 2022).
  14. Cankařová, N.; Krchňák, V. Isocyanide Multicomponent Reactions on Solid Phase: State of the Art and Future Application. Int. J. Mol. Sci. 2020, 21, 9160. [Google Scholar] [CrossRef] [PubMed]
  15. Elinson, M.N.; Ryzhkov, F.V.; Zaimovskaya, T.A.; Egorov, M.P. Non-catalytic Solvent-Free Synthesis of 5,6,7,8-Tetrahydro-4H-chromenes from Aldehydes, Dimedone and Malononitrile at Ambient Temperature. Mendeleev Commun. 2015, 25, 185–187. [Google Scholar] [CrossRef]
  16. Kumaravel, K.; Rajarathinam, B.; Vasuki, G. Water-triggered union of multi-component reactions towards the synthesis of a 4H-chromene hybrid scaffold. RSC Adv. 2020, 10, 29109–29113. [Google Scholar] [CrossRef] [PubMed]
  17. Nasiriani, T.; Javanbakht, S.; Nazeri, M.T.; Farhid, H.; Khodkari, V.; Shaabani, A. Isocyanide-Based Multicomponent Reactions in Water: Advanced Green Tools for the Synthesis of Heterocyclic Compounds. Top. Curr. Chem. (Z) 2022, 380, 50. [Google Scholar] [CrossRef] [PubMed]
  18. Elinson, M.N.; Nasybullin, R.F.; Ryzhkov, F.V.; Egorov, M.P. Solvent-free and ‘on-water’ multicomponent assembling of salicylaldehydes, malononitrile and 3-methyl-2-pyrazolin-5-one: A fast and efficient route to the 2-amino-4-(1H-pyrazol-4-yl)-4H-chromene scaffold. C. R. Chim. 2014, 17, 437–442. [Google Scholar] [CrossRef]
  19. Pirrung, M.C.; Sarma, K.D. Multicomponent reactions are accelerated in water. J. Am. Chem. Soc. 2004, 126, 444–445. [Google Scholar] [CrossRef]
  20. Pirrung, M.C.; Das Sarma, K. Aqueous medium effects on multi-component reactions. Tetrahedron 2005, 61, 11456–11472. [Google Scholar] [CrossRef]
  21. Hudson, R.F.; Saville, B. Solvent participation in nucleophilic displacement reactions. Part I. General considerations. J. Chem. Soc. 1955, 4114–4121. [Google Scholar] [CrossRef]
  22. Abdullah Youssef, A.-R. Solution & Bulk Polymerization. 2019. Available online: https://doi.org/10.13140/RG.2.2.16472.96001/2 (accessed on 1 November 2022).
  23. Weinstein, D.S.; Gong, H.; Doweyko, A.M.; Cunningham, M.; Habte, S.; Wang, J.H.; Holloway, D.A.; Burke, C.; Gao, L.; Guarino, V.; et al. Azaxanthene based selective glucocorticoid receptor modulators: Design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826). J. Med. Chem. 2011, 54, 7318–7833. [Google Scholar] [CrossRef]
  24. Kolokythas, G.; Pouli, N.; Marakos, P.; Pratsinis, H.; Kletsas, D. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives. Eur. J. Med. Chem. 2006, 41, 71–79. [Google Scholar] [CrossRef]
  25. Azuine, M.A.; Tokuda, H.; Takayasu, J.; Enjyo, F.; Mukainaka, T.; Konoshima, T.; Nishino, H.; Kapadia, G. Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models. J. Pharmacol. Res. 2004, 49, 161–169. [Google Scholar] [CrossRef] [PubMed]
  26. Maruyama, Y.; Goto, K.; Terasawa, M. Method for Treatment of Rheumatism. U.S. Patent 4281001, 6 August 1981. [Google Scholar]
  27. Ukawa, K.; Ishiguro, T.; Kuriki, H.; Nohara, A. Synthesis of the metabolites and degradation products of 2-amino-7-isopropyl-5-oxo-5H-(1)benzopyrano(2,3-b)pyridine-3-carboxylic acid (Amoxanox). Chem. Pharm. Bull. 1985, 33, 4432–4437. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Maeda, A.; Tsuruoka, S.; Kanai, Y.; Endou, H.; Saito, K.; Miyamoto, E.; Fujimura, A. Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells. Eur. J. Pharmacol. 2008, 596, 166–172. [Google Scholar] [CrossRef] [Green Version]
  29. Oral, E.A.; Reilly, S.M.; Gomez, A.V.; Meral, R.; Butz, L.; Ajluni, N.; Chenevert, T.L.; Korytnaya, E.; Neidert, A.H.; Hench, R.; et al. Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. Cell Metab. 2017, 26, 157–170. [Google Scholar] [CrossRef] [PubMed]
  30. Ansari, K.R.; Quraishi, M.A.; Singh, A. Chromenopyridin derivatives as environmentally benign corrosion inhibitors for N80 steel in 15% HCl. J. Assoc. Arab. Univ. Basic Appl. Sci. 2017, 22, 45–54. [Google Scholar] [CrossRef] [Green Version]
  31. Gupta, S.; Khurana, J.M. An efficient approach for the synthesis of 5-hydroxy-chromeno[2,3-b]pyridines under catalyst and solvent free conditions. Green Chem. 2017, 19, 4153–4156. [Google Scholar] [CrossRef]
  32. Ghosh, C.K.; Tewari, N.; Morin, C. ChemInform Abstract: Heterocyclic Systems. Part XII. Condensation of 4-OXO-4H-1-BENZOPYRAN-3-CARBONITRILE with Benzoylglycine. Chem. Inf.-Dienst. 1983, 14, 252. [Google Scholar] [CrossRef]
  33. Ryzhkova, Y.E.; Elinson, M.N.; Maslov, O.I.; Fakhrutdinov, A.N. Multicomponent Synthesis of 2-(2,4-Diamino-3-cyano-5H-chromeno[2,3-b]pyridin-5-yl)malonic Acids in DMSO. Molecules 2021, 26, 6839. [Google Scholar] [CrossRef]
  34. Vereshchagin, A.N.; Elinson, M.N.; Anisina, Y.E.; Ryzhkov, F.V.; Goloveshkin, A.S.; Bushmarinov, I.S.; Zlotin, S.G.; Egorov, M.P. Pot, atom and step economic (PASE) synthesis of 5-isoxazolyl-5H-chromeno[2,3-b]pyridine scaffold. Mendeleev Commun. 2015, 25, 424–426. [Google Scholar] [CrossRef]
  35. Vereshchagin, A.N.; Elinson, M.N.; Anisina, Y.E.; Ryzhkov, F.V.; Novikov, R.A.; Egorov, M.P. PASE Pseudo-Four-Component Synthesis and Docking Studies of New 5-C-Substituted 2,4-Diamino-5H-Chromeno[2,3-b]pyridine-3-Carbonitriles. ChemistrySelect 2017, 2, 4593–4597. [Google Scholar] [CrossRef]
  36. Elinson, M.N.; Vereshchagin, A.N.; Anisina, Y.E.; Egorov, M.P. Efficient Multicomponent Approach to the Medicinally Relevant 5-aryl-chromeno[2,3-b]pyridine Scaffold. Polycycl. Aromat. Compd. 2020, 40, 108–115. [Google Scholar] [CrossRef]
  37. Ryzhkova, Y.E.; Ryzhkov, F.V.; Elinson, M.N.; Vereshchagin, A.N.; Egorov, M.P. Pseudo-four-component synthesis of 5-(4-hydroxy-2-oxo-1,2-dihydropyridin-3-yl)-substituted 5H-chromeno[2,3-b]pyridines and estimation of its affinity to sirtuin 2. Arkivoc 2020, 6, 193–208. [Google Scholar] [CrossRef]
  38. Ryzhkov, F.V.; Ryzhkova, Y.E.; Elinson, M.N.; Vorobyev, S.V.; Fakhrutdinov, A.N.; Vereshchagin, A.N.; Egorov, M.P. Catalyst-Solvent System for PASE Approach to Hydroxyquinolinone-Substituted Chromeno[2,3-b]pyridines Its Quantum Chemical Study and Investigation of Reaction Mechanism. Molecules 2020, 25, 2573. [Google Scholar] [CrossRef] [PubMed]
  39. Elinson, M.N.; Ryzhkova, Y.E.; Ryzhkov, F.V. Multicomponent design of chromeno[2,3-b]pyridine systems. Russ. Chem. Rev. 2021, 90, 94–115. [Google Scholar] [CrossRef]
  40. Ali, R.; Mohammad, K.T.; Sobhan, R. A Review on the Syntheses and Applications of the 5H-chromeno[2,3-b]pyridines. Lett. Org. Chem. 2023, 20, 28–53. [Google Scholar] [CrossRef]
  41. Ryzhkova, Y.E.; Elinson, M.N. 2,4-Diamino-5-(5-amino-3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-5H-chromeno[2,3-b]pyridine-3-carbonitrile. Molbank 2022, 2022, M1399. [Google Scholar] [CrossRef]
  42. Osyanin, V.A.; Osipov, D.V.; Klimochkin, Y.N. Convenient one-step synthesis of 4-unsubstituted 2-amino-4H-chromene-2-carbonitriles and 5-unsubstituted 5H-chromeno[2,3-b]pyridine-3-carbonitriles from quaternary ammonium salts. Tetrahedron 2012, 68, 5612–5618. [Google Scholar] [CrossRef]
  43. Kresge, A.J.; Chiang, Y.; Fitzgerald, P.H.; McDonald, R.S.; Schmid, G.H. General acid catalysis in the hydration of simple olefins. Mechanism of olefin hydration. J. Am. Chem. Soc. 1971, 93, 4907–4908. [Google Scholar] [CrossRef]
  44. Patai, S.; Israeli, Y. 411. The kinetics and mechanisms of carbonyl–methylene condensations. Part VII. The reaction of malononitrile with aromatic aldehydes in ethanol. J. Chem. Soc. 1960, 2025–2030. [Google Scholar] [CrossRef]
  45. Oliveira-Pinto, S.; Pontes, O.; Lopes, D.; Sampaio-Marques, B.; Costa, M.D.; Carvalho, L.; Gonçalves, C.S.; Costa, B.M.; Maciel, P.; Ludovico, P.; et al. Unravelling the anticancer potential of functionalized chromeno[2,3-b]pyridines for breast cancer treatment. Bioorg. Chem. 2020, 100, 103942. [Google Scholar] [CrossRef]
  46. Mittelbach, M. An improved and facile synthesis of 2-amino-1,1,3-tricyanopropene. Monatsh. Chem. 1985, 116, 689–691. [Google Scholar] [CrossRef]
Molecules 28 00064 g001 550
Figure 1. 5-O-chromeno[2,3-b]pyridines with proven useful properties.
Figure 1. 5-O-chromeno[2,3-b]pyridines with proven useful properties.
Molecules 28 00064 g001
Molecules 28 00064 sch001 550
Scheme 1. Multicomponent synthesis of 2,4-diamino-5-phenoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile.
Scheme 1. Multicomponent synthesis of 2,4-diamino-5-phenoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile.
Molecules 28 00064 sch001
Molecules 28 00064 sch002 550
Scheme 2. The transformation of salicylaldehyde 1a and malononitrile dimer 2 into chromene 5a.
Scheme 2. The transformation of salicylaldehyde 1a and malononitrile dimer 2 into chromene 5a.
Molecules 28 00064 sch002
Molecules 28 00064 g002 550
Figure 2. 5-Alkoxy-5H-chromeno[2,3-b]pyridine 4.
Figure 2. 5-Alkoxy-5H-chromeno[2,3-b]pyridine 4.
Molecules 28 00064 g002
Molecules 28 00064 sch004 550
Scheme 4. Mechanism of salicylaldehydes 1, malononitrile dimer 2 and alcohol 3 transformation into 5-O-chromeno[2,3-b]pyridines 4.
Scheme 4. Mechanism of salicylaldehydes 1, malononitrile dimer 2 and alcohol 3 transformation into 5-O-chromeno[2,3-b]pyridines 4.
Molecules 28 00064 sch004
Molecules 28 00064 g003 550
Figure 3. The structure of chromeno[2,3-b]pyridine 4d. Key 1H-13C-HMBC NMR correlations are shown by arrows.
Figure 3. The structure of chromeno[2,3-b]pyridine 4d. Key 1H-13C-HMBC NMR correlations are shown by arrows.
Molecules 28 00064 g003
Molecules 28 00064 g004 550
Figure 4. 1H-13C HMBC NMR spectrum of 2,4-diamino-5,8-dimethoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4d in DMSO-d6 (400 MHz, 298 K).
Figure 4. 1H-13C HMBC NMR spectrum of 2,4-diamino-5,8-dimethoxy-5H-chromeno[2,3-b]pyridine-3-carbonitrile 4d in DMSO-d6 (400 MHz, 298 K).
Molecules 28 00064 g004
Table
Table 2. One-pot reaction of salicylaldehydes 1a–c, malononitrile dimer 2 and alcohols 3a–c 1.
Table 2. One-pot reaction of salicylaldehydes 1a–c, malononitrile dimer 2 and alcohols 3a–c 1.
Molecules 28 00064 i001
Molecules 28 00064 i002
1 Reaction conditions: salicylaldehyde 1a–c (1 mmol), malononitrile dimer 2 (1 mmol), and triethylamine (0.1 mmol) were stirred in 10 mL of corresponding alcohol 3a–c for 1 h. Then, another portion of alcohol 3a–c (20 mL) was added, and reaction mixture was heated at reflux for 30 min. Isolated yields.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ryzhkova, Y.E.; Ryzhkov, F.V.; Elinson, M.N.; Maslov, O.I.; Fakhrutdinov, A.N. One-Pot Solvent-Involved Synthesis of 5-O-Substituted 5H-Chromeno[2,3-b]pyridines. Molecules 2023, 28, 64. https://doi.org/10.3390/molecules28010064

AMA Style

Ryzhkova YE, Ryzhkov FV, Elinson MN, Maslov OI, Fakhrutdinov AN. One-Pot Solvent-Involved Synthesis of 5-O-Substituted 5H-Chromeno[2,3-b]pyridines. Molecules. 2023; 28(1):64. https://doi.org/10.3390/molecules28010064

Chicago/Turabian Style

Ryzhkova, Yuliya E., Fedor V. Ryzhkov, Michail N. Elinson, Oleg I. Maslov, and Artem N. Fakhrutdinov. 2023. "One-Pot Solvent-Involved Synthesis of 5-O-Substituted 5H-Chromeno[2,3-b]pyridines" Molecules 28, no. 1: 64. https://doi.org/10.3390/molecules28010064

Article Metrics

Back to TopTop